Citigroup’s Boundless Bio BOLD Stock Holding History

Citigroup’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,837	Closed	-$9.72K	–	6325
2026 Q1	$9.72K	Sell	8,837 -16,236	-65%	-$19K	﹤0.01%	5053
2025 Q4	$30.1K	Buy	+25,073	New	+$31.2K	﹤0.01%	4748
2025 Q3	–	Sell	-2,551	Closed	-$2.58K	–	6358
2025 Q2	$2.58K	Sell	2,551 -9,319	-79%	-$12.4K	﹤0.01%	5344
2025 Q1	$17.9K	Sell	11,870 -1,436	-11%	-$2.98K	﹤0.01%	5109
2024 Q4	$38.6K	Buy	13,306 +8,738	+191%	+$25.5K	﹤0.01%	5145
2024 Q3	$15.9K	Buy	4,568 +3,162	+225%	+$11.5K	﹤0.01%	5224
2024 Q2	$5.44K	Buy	+1,406	New	+$13.4K	﹤0.01%	5249

Other funds holding BOLD

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

FMP

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citigroup's BOLD Position: Q2 2026 in Review

Citigroup sold out of Boundless Bio (BOLD) in Q2 2026, closing a stake of 8,837 shares — an estimated $9.72K sold.

Citigroup first reported a position in BOLD in Q2 2024 and held it in 7 quarters. The position peaked at $38.6K in Q4 2024. 4 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Citigroup reported no remaining Boundless Bio position as of Q2 2026 after selling out during the quarter.
Citigroup sold 8,837 Boundless Bio shares in Q2 2026, an estimated $9.72K.
Citigroup first reported a position in Boundless Bio in Q2 2024 and held it in 7 quarters.
Citigroup's Boundless Bio position peaked at $38.6K in Q4 2024.
4 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.